Skip to main content
. 2021 Jan 27;36(1):75–86. doi: 10.1093/mutage/geab005

Table 1.

Treatment concentrations. Typical values from the literature are shown for comparison

DT40 treatment concentration (µM) TK6 treatment concentration (µM) Clinical usage
Platinum drug IC25 IC50 IC25 IC50 Peak unbound plasma conc. (µM) Reference Elimination half-life of free drug in plasma Reference
Cisplatin 7.5 10 4 6 1.3 (48) 0.6 h (45)
Carboplatin 75 110 60 120 38.5 (47) 2 h (45)
Oxaliplatin 2.5 4.5 2 4 1.2 (49) 1.7 h (46)